Release Date: 24/03/16 10:30 Summary: Notice under section 630(2) of the Corporations Act Price Sensitive: No Download Document 41.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%